Results 141 to 150 of about 1,630,140 (194)

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach From the Writing Committee of the American Society for Apheresis: The Tenth Special Issue. [PDF]

J Clin Apher
Zantek ND, Alquist CR, Hofmann JC, Klingel R, Levenbrown Y, Onwuemene OA, Patidar G, Patriquin CJ, Raval JS, Sanchez AP, Schneiderman J, Tanhehco YC, Connelly-Smith L.   +12 more
europepmc   +1 more source

Guidance for Documentation of Therapeutic Apheresis Interventions in the Medical Record: An American Society for Apheresis (ASFA) Practice Perspective. [PDF]

J Clin Apher
Andrzejewski C, Li Y, Wu DW, De Ridder G, Hofmann JC, Knight S, Hassan S, Aqui NA, Linz W.   +8 more
europepmc   +1 more source

Therapeutic apheresis: A promising method to remove microplastics? [PDF]

Brain Med
Bornstein SR, Gruber T, Katsere D, El Attaoui A, Wohlsperger L, Yaman M, Kanczkowski W, Piwernetz G, Straube R, Voit-Bak K, Licinio J, Steenblock C.   +11 more
europepmc   +1 more source

Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan. [PDF]

Ther Apher Dial, 2020
Kusaoi M, Murayama G, Tamura N, Yamaji K.   +3 more
europepmc   +1 more source

When Strong Recommendations Rest on Weak Evidence: Lessons From Therapeutic Apheresis Guidelines. [PDF]

J Clin Apher
Jacobs JW, Booth GS, Adkins BD, Costa V, Raza S, Park YA, Schwartz JY, Bloch EM.   +7 more
europepmc   +1 more source

Therapeutic apheresis within immune-mediated neurological disorders: dosing and its effectiveness. [PDF]

Sci Rep, 2020
Klingele M, Allmendinger C, Thieme S, Baerens L, Fliser D, Jan B.   +5 more
europepmc   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone-Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single-Center Case Series. [PDF]

Ther Apher Dial
Horiguchi W, Katagiri D, Watadani T, Matsuda S, Kaneko H, Arai N.   +5 more
europepmc   +1 more source

Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. [PDF]

Pharmaceutics, 2020
Filip S, Kubeček O, Špaček J, Lánská M, Bláha M.   +4 more
europepmc   +1 more source

Therapeutic Apheresis. [PDF]

Transfus Med Hemother, 2019
Mansouri Taleghani B, Buser A.
europepmc   +1 more source

Hemodynamic Effect of Different Replacement Fluid Protocols During Therapeutic Apheresis Evaluated With CRIT-LINE. [PDF]

J Clin Apher
Elassas H, Moranne O.
europepmc   +1 more source